NIH

Metformin use is associated with reduced cancer risk

April 25, 2024 - Two recent studies published in the Journal of the National Cancer Institute have correlated metformin use with lower cancer risks, implying that the drug may offer some protection against the illness. The first of these studies was a systematic review and meta-analysis published earlier this year. Researchers used databases such as PubMed,...

Read More


More Articles

NIH researchers develop AI tool for personalized oncology

by Veronica Salib

On April 18, 2024, researchers from the National Institutes of Health (NIH) published a proof-of-concept study in Nature Cancer detailing a new artificial intelligence (AI) tool to match patients with...

Semaglutide Minimizes MASLD Severity in Patients with HIV

by Veronica Salib

On Tuesday, March 5, 2024, the NIH issued a release linking semaglutide use with a decreased severity of metabolic dysfunction-associated steatotic liver disease (MASLD) in HIV-positive patients,...

NIH Launches Cancer Screening Research Network for Early Detection

by Veronica Salib

On Wednesday, February 21, 2024, the NIH launched a clinical trial network for evaluating new cancer detection technologies or methods called the Cancer Screening Research Network (CSRN), which will...

Injectable HIV ART Is an Effective Alternative to Oral Medications

by Veronica Salib

On February 21, 2024, the NIH issued a press announcement revealing that long-acting injectable antiretroviral therapy (ART) using cabotegravir and rilpivirine was more effective than oral ART at...

What Is the Role of the Accelerating Medicines Partnership?

by Veronica Salib

Last week, the Foundation for the National Institutes of Health (FNIH) held its inaugural Accelerating Medicines Partnership (AMP) Program Symposium, discussing the progress of multiple AMP projects. Julie Gerberding, MD, MPH, President...

Comparing Female Fertility Drugs: Use Cases, Effectiveness, Risks

by Veronica Salib

Infertility, or the inability to conceive, is characterized by one year of unprotected sex without a subsequent pregnancy. Although infertility can result from male or female partners, most available fertility drugs work on addressing...

NIH-Developed Antibodies Neutralize HIV in Animal Studies

by Veronica Salib

On January 17, 2024, the National Institutes of Health (NIH) issued a media advisory announcing the results of a proof-of-concept identifying three antibodies that protect against various human...

Ethical Guidelines, Emerging Regulations in Octopus Research

by Alivia Kaylor

With their unique biological features, octopuses have become valuable subjects in medical research. Their extraordinary abilities, such as camouflage, regenerative capabilities, and highly developed nervous systems, make them captivating...

NIH Alters Grant Review Process, Focusing on Scientific Merit

by Veronica Salib

On October 19, 2023, the National Institutes of Health (NIH) announced plans to alter and simplify its grant review process, attempting to eliminate reputational bias in grant allocation. The updated...

FDA Approves Non-Opioid Painkiller for Mild-to-Moderate Pain

by Veronica Salib

Earlier this week, Hyloris Pharmaceuticals, a pharmaceutical company headquartered in Belgium, announced the approval of a potent non-opioid painkiller in the United States. The US Food and Drug...

FDA Proposes Ban on Formaldehyde Hair Smoothing, Straightening Products

by Veronica Salib

A proposed rule by the United States Food and Drug Administration (FDA) and the US Department of Health and Human Services (HHS) has proposed banning hair products that contain formaldehyde or...

CDC Recommends Doxycycline PEP to Prevent STIs

by Veronica Salib

Earlier this week, the Centers for Disease Control and Prevention (CDC) published a draft guidance for the use of doxycycline, a common antibiotic, as a post-exposure prophylaxis (PEP) treatment to...

HIV Vaccine Clinical Trials Begin in the US and South Africa

by Veronica Salib

Yesterday, the National Institute of Allergy and Infectious Disease (NIAID), a subset of the National Institutes of Health (NIH), revealed that phase 1 vaccine trials for human immunodeficiency virus...

Only 3.3% of NIH-Funded Pediatric Clinical Trials Data Is Reusable

by Veronica Salib

In a research letter published in JAMA Network Open on July 25, 2023, scientists evaluated data availability from pediatric clinical trials funded by the National Institutes of Health (NIH). According...

Men in the US Are More Likely to Have a Fatal Overdose Than Women

by Veronica Salib

As the opioid epidemic in the United States continues to progress, a recent study revealed that men are more likely to have a fatal overdose than women. Data from a study — led by researchers...

Government Health Leaders Request Additional Data on Drug Test Strips

by Veronica Salib

Although drug-checking tools such as fentanyl test strips have been championed as critical harm-reduction tools in the opioid epidemic, additional data and research are required to assess their...

National Cancer Institute Launches Precision Medicine Initiative

by Veronica Salib

On June 1, 2023, the National Cancer Institute (NCI), a subset of the NIH, launched ComboMATCH, a precision medicine initiative for cancer patients. ComboMATCH — short for Combination Therapy...

NIH Researchers Begin Clinical Trials on a Universal Influenza Vaccine

by Veronica Salib

The NIH’s National Institute of Allergy and Infectious Disease (NIAID) Vaccine Research Center (VCR) researchers have begun phase 1 clinical trials on a universal mRNA influenza vaccine. The...

How Do NIH Funding Requirements Impact Researcher Demographics?

by Veronica Salib

An analysis of the impact of the National Institutes of Health (NIH) funding requirements determined that they improve diversity in medical scientist training programs (MSTPs). The data revealed more...

Recent Articles